Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$614M |
| 2 |
Apple
AAPL
|
+$555M |
| 3 |
Amazon
AMZN
|
+$318M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$314M |
| 5 |
Ralph Lauren
RL
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SBA Communications
SBAC
|
+$202M |
| 2 |
Ross Stores
ROST
|
+$193M |
| 3 |
RTX Corp
RTX
|
+$192M |
| 4 |
Prudential Financial
PRU
|
+$162M |
| 5 |
Philip Morris
PM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 10.03% |
| 2 | Consumer Discretionary | 9.13% |
| 3 | Energy | 6.65% |
| 4 | Technology | 6.5% |
| 5 | Healthcare | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PWE
4176
CALL
DELISTED
Penn West Energy Petroleum Ltd
PWE
| $391K | ﹤0.01% |
46,800
+27,600
| +144% | +$265K |
|
|
OREX
4177
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $391K | ﹤0.01% |
6,938
-127,598
| -95% | -$7.17M |
|
|
TCO
4178
PUT
DELISTED
Taubman Centers Inc.
TCO
| $390K | ﹤0.01% |
6,100
+1,800
| +42% | +$120K |
|
|
ECYT
4179
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $390K | ﹤0.01% |
+36,448
| New | +$402K |
|
|
CSII
4180
DELISTED
Cardiovascular Systems, Inc.
CSII
| $389K | ﹤0.01% |
11,339
-3,965
| -26% | -$115K |
|
|
PGNX
4181
PUT
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $389K | ﹤0.01% |
73,000
+54,700
| +299% | +$241K |
|
4182
CALL
Scotiabank
BNS
$108B
| $388K | ﹤0.01% |
6,672
-969
| -13% | -$54.3K |
|
4183
Santander
BSBR
$43.5B
| $387K | ﹤0.01% |
+66,237
| New | +$417K |
|
4184
CALL
Medifast
MED
$141M
| $387K | ﹤0.01% |
14,800
+500
| +3% | +$12.8K |
|
4185
PUT
Vera Bradley
VRA
$98.7M
| $387K | ﹤0.01% |
16,100
-11,700
| -42% | -$268K |
|
|
BONT
4186
CALL
DELISTED
Bon-Ton Stores Inc/The
BONT
| $386K | ﹤0.01% |
23,700
+16,200
| +216% | +$226K |
|
|
AVNR
4187
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $386K | ﹤0.01% |
115,076
-26,739
| -19% | -$110K |
|
4188
Globe Life
GL
$14.3B
| $385K | ﹤0.01% |
7,391
+5,115
| +225% | +$255K |
|
4189
Mercer International
MERC
$39.8M
| $385K | ﹤0.01% |
38,548
-17,958
| -32% | -$160K |
|
4190
CALL
Power Integrations
POWI
$3.61B
| $385K | ﹤0.01% |
13,800
-200
| -1% | -$5.4K |
|
4191
PUT
Visteon
VC
$2.78B
| $385K | ﹤0.01% |
4,700
+800
| +21% | +$61.8K |
|
|
INFN
4192
CALL
DELISTED
Infinera Corporation Common Stock
INFN
| $385K | ﹤0.01% |
39,400
-26,300
| -40% | -$261K |
|
|
CBR
4193
DELISTED
CIBER Inc.
CBR
| $385K | ﹤0.01% |
93,100
+30,258
| +48% | +$108K |
|
|
VIVS
4194
VivoSim Labs
VIVS
$1.64M
| $384K | ﹤0.01% |
+144
| New | +$283K |
|
|
WMGI
4195
PUT
DELISTED
Wright Medical Group Inc
WMGI
| $384K | ﹤0.01% |
12,500
+1,000
| +9% | +$28.3K |
|
|
OCIP
4196
CALL
DELISTED
OCI Partners LP
OCIP
| $384K | ﹤0.01% |
+13,900
| New | +$330K |
|
|
OVTI
4197
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $384K | ﹤0.01% |
22,349
-38,056
| -63% | -$577K |
|
|
FPO
4198
DELISTED
First Potomac Realty Trust
FPO
| $384K | ﹤0.01% |
33,114
+22,619
| +216% | +$270K |
|
4199
America Movil
AMX
$71.2B
| $383K | ﹤0.01% |
16,401
-264,937
| -94% | -$5.78M |
|
4200
PUT
Manulife Financial
MFC
$73.5B
| $383K | ﹤0.01% |
19,400
-5,100
| -21% | -$93.3K |
|
Similar funds
Citadel Advisors's Q4 2013 Portfolio in Review
As of Q4 2013, Citadel Advisors held 7,546 positions worth $76.8B, up 17% from $65.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Citadel Advisors's Q4 2013 filing shows 827 new, 3,072 increased, 2,907 reduced and 547 closed positions. Its largest new stake was Antero Resources: 2,586,508 shares worth $164M. The largest sale was SBA Communications, an estimated $202M.
By sector, the portfolio is most concentrated in Financials at 10% of assets, up from 9.5% a quarter earlier, followed by Consumer Discretionary and Energy.
- Citadel Advisors's largest Q4 2013 buy was Antero Resources: 2,586,508 shares worth $164M.
- Citadel Advisors added most to Alphabet (Google) Class C in Q4 2013, an estimated $614M increase.
- Citadel Advisors's biggest Q4 2013 reduction was SBA Communications, cutting an estimated $202M.
- Citadel Advisors fully exited ELAN CORP ADS(RP1 ORD4IRISH PN in Q4 2013, selling an estimated $100M.
- Citadel Advisors's ten largest holdings make up 13% of its $76.8B portfolio in Q4 2013.
- Citadel Advisors opened 827 new positions and closed 547 in Q4 2013.
- Citadel Advisors's portfolio value rose 17% quarter-over-quarter to $76.8B.
Based on Citadel Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.